ABIOMED Inc (NASDAQ:ABMD)
| 266.92 Delayed Data As of Nov 23 |  -1.78 / -0.66%Today’s Change | 119.01 Today|||52-Week Range 319.19 | +56.47% Year-to-Date |
Latest ABMD News | Press Releases
| 3 Best Buys from the Prospering Medical Instruments Industry Nov 18 / Zacks.com - Paid Partner Content | These 3 Medical Device Stocks Leave Biotech in the Dust Nov 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 268.21 |
| Today’s open | 268.10 |
| Day’s range | 265.35 - 271.68 |
| Volume | 240,306 |
| Average volume (3 months) | 309,573 |
| Market cap | $12.1B |
Data as of 4:00pm ET, 11/23/2020
Growth & Valuation
| Earnings growth (last year) | -22.09% |
| Earnings growth (this year) | +3.77% |
| Earnings growth (next 5 years) | +17.10% |
| Revenue growth (last year) | +9.29% |
| P/E ratio | 58.7 |
| Price/Sales | 7.91 |
| Price/Book | 11.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PENPenumbra Inc | -0.07 | -0.03% |
| TFXTeleflex Inc | +0.18 | +0.05% |
| PODDInsulet Corp | +0.65 | +0.25% |
| ---- |
Data as of 4:00pm ET, 11/23/2020
Financials
| Next reporting date | February 4, 2021 |
| EPS forecast (this quarter) | $1.12 |
| Annual revenue (last year) | $840.9M |
| Annual profit (last year) | $203.0M |
| Net profit margin | 24.14% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Danvers, Massachusetts |
Forecasts
